Apellis Pharmaceuticals, Inc. (APLS) Earnings
|
Expand Research on APLS
| Next EPS Date | 5/2/24 | EPS Growth Rate | -129.5% |
|---|---|---|---|
| Average EPS % Beat Rate | +0.4% | Revenue Growth Rate | +259.7% |
| Average % Move 1-Wk after EPS | -2.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/2/24 | Q124 | N/A | -$0.46 | N/A | N/A | $161.28M | N/A | N/A | N/A | ||
2/27/24  |
Q423 | N/A | -$0.73 | N/A | N/A | $141.43M | N/A | N/A | N/A | ||
| 11/1/23 | Q323 | -$1.17 | -$0.99 | -$0.18 | $110.4M | $99.38M | N/A |  | | Details | |
| 7/31/23 |
Q223 | -$1.02 | -$1.36 | +$0.34 | $95M | $70.24M | N/A | | | Details | |
| 5/4/23 | Q123 | $1.56 | $1.66 | -$0.10 | $44.84M | $26.1M | N/A | | | Details | |
| 2/27/23 | Q422 | N/A | -$1.51 | N/A | N/A | $24.26M | N/A | N/A | N/A | ||
| 2/21/23 | Q422 | -$1.50 | -$1.51 | +$0.01 | $22.7M | $24.26M | N/A | | | Details | |
| 11/7/22 | Q322 | -$1.75 | -$1.44 | -$0.31 | $17.7M | $21.74M | N/A | | | Details |
